Any provider prescribing compounded GLP-1 formulations should be tracking your progress with periodic bloodwork and, ideally, body composition measurements (DEXA scan or bioimpedance) rather than relying solely on scale weight
Pregnancy and breastfeeding are stopping points: concentrated methyl-donor combinations are not well studied in pregnancy, and guidance is to avoid Lipo-C unless a clinician judges maternal benefit to outweigh theoretical risk under obstetric supervision
doi:10.3389/fpsyg.2015.01520
The same study confirmed dose-dependent increases in GH without significant changes in other pituitary hormones (prolactin, TSH, LH, FSH, cortisol), supporting its selectivity for the GH axis
This research does not provide a peptide treatment but rather identifies a peptide pathway that could be targeted to reduce eczema-associated itch, potentially through BNP receptor antagonists